Unlock stock picks and a broker-level newsfeed that powers Wall Street.
312.85
-22.20
(-6.63%)
At close: April 4 at 9:39:52 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 15 | 24 | 23 |
| Avg. Estimate | 13.67B | 13.72B | 55.15B | 55.94B |
| Low Estimate | 13.59B | 13.63B | 54.67B | 54.18B |
| High Estimate | 13.74B | 13.81B | 55.69B | 57.09B |
| Year Ago Sales | 13.68B | 13.69B | 55.09B | 55.15B |
| Sales Growth (year/est) | -0.06% | 0.26% | 0.11% | 1.43% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CQD.F | -- | -- | -- | -- |
| S&P 500 | 6.59% | 6.64% | 9.81% | 16.08% |
Upgrades & Downgrades
| Maintains | Barclays: Underweight to Underweight | 2/3/2025 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 2/3/2025 |
| Reiterates | Benchmark: Buy to Buy | 1/31/2025 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 1/15/2025 |
| Upgrade | Keybanc: Sector Weight to Overweight | 12/12/2024 |
| Upgrade | Exane BNP Paribas: Underperform to Neutral | 11/26/2024 |